Related to Scientists Claim Leukemia Stem Cell Signature Independently Predicts Poor Survival in AML

• Clavis Raises About $20M to Progress Clinical Anticancer Pipeline
  
• Cellular Dynamics Gains Patent Portfolio for Using Stem Cell-Derived Cells in Drug Screening
  
• Scientists Identify Bladder Cancer Stem Cells
  
• Novartis Acquires Opexa’s Stem Cell Technology for $4M
  
• Tumor Suppressor p53 Also Stifles Cells from Reverting to Stem-Like State
  
• Scientists Create Multiple Types of WBCs from hESCs and iPSCs
  
• S-Evans Biosciences Gains Chinese Rights to Cryo-Cell’s Menstrual Stem Cell Technology
  
• BrainStorm Cell Therapeutics Taps Israeli CMO for Stem Cell Production
  
• BioTime Sets Up Subsidiary in China to Develop Stem Cell Therapeutics
  
• Scientists Find Major Role for GSK-3 Gene in Embryonic Brain Development
  
• Russian Stem Cell Company Hopes to Raise Roughly $5.54M through IPO on Moscow Stock Exchange
  
• hESCs May Serve As a Colon Cancer Vaccine
  
• Kinaxo to Help Bayer Predict Patient Response to Nexavar in AML Clinical Trial
  
• BioTime Sets Up Subsidiary to Develop hESC-Based Therapies for Cancer
  
• Induced Pluripotent Stem Cell Technology Used to Generate Hepatocytes from Skin Cells
  
• Cellerix to Test Gamida’s Expansion Technologies with Its Stem Cell-Based Drugs
  
• Johns Hopkins Gets $3.7M Two-Year Grant from NIH to Study ALS
  
• Researchers Create iPSCs from Somatic Cells without Exogenous Transcription Factors
  
• Researchers Elucidate How Bone Marrow Derived Stem Cells Can Be Used in Acute Lung Injury
  
• Kyoto Buys Fluidigm’s Technology to Research Stem Cell Reprogramming